AXA SA vs The Procter & Gamble Company: Strategic Comparison
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Key Differences at a Glance
| Field | AXA SA | The Procter & Gamble Company |
|---|---|---|
| Revenue | $110.2B | $84.0B |
| Founded | 1816 | 1837 |
| Employees | 147,000 | 107,000 |
| Market Cap | $79.8B | $395.0B |
| Headquarters | France | United States |
| Revenue / Employee | $750k / employee | $785k / employee |
| Valuation Multiple | 0.7x P/S | 4.7x P/S |
Current Strategic Alignment & Momentum
Executive Catalyst & Theme Analysis (September 2026)
AXA SA Strategic Vector
FY2025 Baseline*Strategic Analysis (September 2026 Update):* As AXA SA navigates the Multiline Insurance & Asset Management market from its headquarters in Paris, France (founded in 1816), a pivotal strategic theme is **Workflow Automation**. With reported annual revenue of $110.2B (FY2025) and a global workforce of 147,000 employees, the company's execution on workflow automation will directly influence its market share against peers such as Allianz, Prudential, Metlife.
The Procter & Gamble Company Strategic Vector
FY2025 Baseline*Strategic Analysis (September 2026 Update):* As The Procter & Gamble Company navigates the Consumer packaged goods market from its headquarters in Cincinnati, Ohio, United States (founded in 1837), a pivotal strategic theme is **Workflow Automation**. With reported annual revenue of $84.0B (FY2025) and a global workforce of 107,000 employees, the company's execution on workflow automation will directly influence its market share against peers such as Unilever, Colgate palmolive, Kimberly clark.
Quick Stats Comparison
| Metric | AXA SA | The Procter & Gamble Company |
|---|---|---|
| Revenue | $110.2B | $84.0B |
| Founded | 1816 | 1837 |
| Headquarters | Paris, France | Cincinnati, Ohio, United States |
| Market Cap | $79.8B | $395.0B |
| Employees | 147,000 | 107,000 |
| Revenue / Employee | $750k / employee | $785k / employee |
| Valuation Multiple | 0.7x P/S | 4.7x P/S |
AXA SA Revenue vs The Procter & Gamble Company Revenue — Year by Year
| Year | AXA SA | The Procter & Gamble Company | Leader |
|---|---|---|---|
| 2025 | $133.4B | $84.3B | AXA SA |
| 2024 | $119.5B | $84.0B | AXA SA |
| 2023 | $111.2B | $82.0B | AXA SA |
| 2022 | $110.3B | N/A | AXA SA |
Business Model Breakdown
Overview: AXA SA vs The Procter & Gamble Company
This in-depth comparison examines AXA SA and The Procter & Gamble Company across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching AXA SA on its own, evaluating The Procter & Gamble Company, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between AXA SA and The Procter & Gamble Company is widest.
On the headline numbers, AXA SA reports annual revenue of $110.2B against $84.0B for The Procter & Gamble Company, while their respective market capitalizations stand at $79.8B and $395.0B. AXA SA is headquartered in France and The Procter & Gamble Company operates from United States, and those different home markets shape how each company competes.
AXA SA: AXA maintains a natural catastrophe load of approximately 4. By 2024, that modest mutual, now known as AXA, generated EUR116 billion in gross written premiums and other revenues, served +92 million clients across 50 countries, and managed €983 billion in assets. These deals transformed AXA from a mid-tier French player into the world's second-largest insurer by 1996. The P&C segment generated €56.5 billion in gross written premiums in 2024, representing approximately 51% of total revenues. This segment is split between commercial lines (€34.9 billion), personal lines (€19.1 billion), and AXA XL Reinsurance (€2.5 billion). The all-year combined ratio for P&C was 91.0% in 2024, down 2.1 percentage points from 2023, reflecting disciplined underwriting and favorable prior-year reserve development of 1.6%. The life & savings segment contributed €52.0 billion in gross written premiums in 2024, split between life insurance (€34.5 billion) and health (€17.5 billion). However, AXA made the strategic decision in 2024 to sell AXA IM to BNP Paribas for approximately €5.1 billion, completing the transaction in July 2025. Capital management is central to AXA's core offering. In 2024, AXA paid a dividend of €2.15 per share and executed €1.8 billion in share buybacks. The Solvency II ratio of 216% provides a substantial buffer above regulatory minimums, supporting both the dividend policy and strategic flexibility. AXA is one of the world's largest and most diversified insurance groups, with a presence in 50 countries and a balanced portfolio of property & casualty, life & savings, and health insurance. The US life market is dominated by MetLife, Prudential Financial, and Northwestern Mutual, while commercial P&C is led by Chubb, Travelers, and Liberty Mutual. Gross written premiums and other revenues reached EUR116 billion, up 7% on a reported basis and 8% on a comparable basis (constant forex and scope). The P&C segment was the standout performer. Underlying earnings reached €5.5 billion, up 10%, driven by a 2.1 percentage point improvement in the combined ratio to 91.0%. The current year loss ratio excluding natural catastrophes improved by 1.0 percentage point, reflecting underwriting actions in response to 2023's elevated motor claims frequency in the UK and Germany. Prior-year reserve development was favorable at 1.6%, contributing €0.9 billion to earnings. The natural catastrophe load was 3.8% of earned premiums, below the 4.5% budget, demonstrating the impact of portfolio re-underwriting discipline. AXA XL's underlying earnings grew 29% to €2.0 billion, with a combined ratio of 91.7%. Life & health underlying earnings were €3.3 billion, up 4% on a constant exchange rate basis. Life earnings were flat at €2.6 billion, reflecting the impact of in-force transactions and market conditions. Net flows in life & health turned positive at €1.5 billion in 2024, a significant improvement from the €4.1 billion outflow in 2023, driven by strong health and protection inflows. The balance sheet remains solid. Surprisingly, Shareholders' equity was €49.9 billion at year-end 2024, and the Solvency II ratio stood at 216%, providing a substantial capital cushion. The underlying return on equity was 15.2% in 2024, up 0.3 percentage points from 2023 and above the strategic plan target range of 14-16%. The 2024 California wildfires alone contributed an estimated €0.1 billion in losses, net of reinsurance. Climate change is intensifying the frequency and severity of weather-related events, making historical loss models potentially less predictive. The combined ratio for AXA XL improved to 91.7% in 2024, demonstrating successful underwriting integration. AXA's Solvency II ratio of 216% and shareholders' equity of €49.9 billion provide substantial buffers above regulatory requirements. In Asia AXA is capitalizing on the protection gap in emerging markets and the demand for unit-linked products in developed markets like Japan and Hong Kong. AXA has implemented IT productivity and automation programs, particularly at AXA XL and in the UK & Ireland, to reduce expense ratios. Management expressed confidence in meeting these targets during the 2024 earnings presentation, citing strong operational momentum and disciplined capital management. The story of AXA begins not in a Paris boardroom but in the ashes of post-Napoleonic Normandy. In 1881, these entities merged under the name Ancienne Mutuelle, which would remain unchanged until 1977. After a stint in Canada developing life insurance business, Bébéar returned to France and was appointed general manager in 1975 following a two-month strike that paralyzed the company. This deal propelled Mutuelles Unies into the top tier of French insurers. In 1985, the group was officially renamed AXA — a name chosen because it had no meaning, was internationally pronounceable and was an easily remembered palindrome. The company targets cost operational efficiencies from acquisitions and organic efficiency improvements to support margin expansion. The P&C business is expected to remain the primary earnings driver. The company has also announced the acquisition of Nobis in Italy, strengthening its position in the Italian P&C market. The company's diversification and capital strength provide buffers against these risks, but the global insurance cycle remains a key variable. For over a century, the company — later known as Ancienne Mutuelle — remained a regional French mutual insurer. Bébéar changed the company's name to Mutuelles Unies in 1978, reflecting a new spirit of unity and ambition.
The Procter & Gamble Company: P&G is a global consumer packaged goods company selling daily-use brands such as Tide, Pampers, Dawn, Gillette, Oral-B, Crest, Olay, Always, Bounty, and Charmin. FY2025 net sales were $84.284 billion. The most useful way to read the company is through its revenue model, leadership, competitive position, and the specific risks that can weaken the strategy.
Business Models: How AXA SA and The Procter & Gamble Company Make Money
AXA SA and The Procter & Gamble Company pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between AXA SA and The Procter & Gamble Company.
AXA SA business model: AXA operates a, diversified global insurance and asset management model. Historically reliant on traditional life insurance and savings products, the modern company executed a significant, strategic pivot. It sold off its volatile, interest-rate-sensitive US life insurance business to focus almost entirely on high-margin, complex "Property & Casualty" (P&C) insurance, specifically targeting considerable global corporations and specialized commercial risks.
The Procter & Gamble Company business model: P&G makes money by selling branded consumer goods across fabric care, home care, baby care, feminine care, family care, beauty, grooming, oral care, and personal health categories. This ensures long-term operational success and structural market dominance across the broader landscape. The organization secures its financial future through flawless consumer mastery. This ensures survival. This ensures long-term operational success and structural market dominance across the broader landscape. The organization secures its financial future through flawless consumer mastery. This ensures survival.
Competitive Advantage: AXA SA vs The Procter & Gamble Company
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of AXA SA stack up against those of The Procter & Gamble Company.
AXA SA competitive advantage: With a Solvency II ratio of 216% and an all-year P&C combined ratio of 91.0% in 2024, AXA combines scale with underwriting discipline in a way that few global insurers can match. This diversification is the company's core strategic advantage, allowing it to balance cyclical P&C underwriting with the more stable, long-duration cash flows of life and health insurance. With 156,000 employees, +92 million clients, and €983 billion in assets under management, AXA combines scale with underwriting discipline to generate consistent returns for shareholders. AXA's scale provides advantages in data and pricing sophistication, but the company must continuously invest in digital capabilities to maintain competitiveness. AXA's primary competitive advantage lies in its unmatched geographic and product diversification. Scale generates meaningful data advantages in insurance pricing and risk selection. The company's investment in digital platforms, including AI-driven claims processing and customer service automation, leverages this data advantage to reduce expense ratios and improve customer experience. The mutual company structure at the top of the AXA group provides an unique governance advantage. Capital strength is a critical competitive advantage in insurance, where the ability to pay claims during catastrophic events determines long-term viability.
The Procter & Gamble Company competitive advantage: P&G's advantage comes from daily-use brands, global distribution, retail relationships, R&D scale, marketing muscle, and category leadership.
Growth Strategy: Where AXA SA and The Procter & Gamble Company Are Headed
Future prospects matter as much as current results. The growth strategies below explain how AXA SA and The Procter & Gamble Company each plan to expand from here.
AXA SA growth strategy: AXA is focused on commercial P&C margins, life and health growth, disciplined capital return, automation, AI-enabled efficiency, and the post-AXA IM portfolio mix.
The Procter & Gamble Company growth strategy: P&G's strategy centers on product superiority, portfolio focus, productivity, constructive disruption, retail execution, innovation, and organization agility.
Financial Picture: AXA SA vs The Procter & Gamble Company
A closer look at the financial trajectory of AXA SA and The Procter & Gamble Company rounds out the comparison.
AXA SA: AXA has transformed from a complex global financial conglomerate into a streamlined, high-margin commercial insurer. Under CEO Thomas Buberl, the Paris-based company generated exactly $110.2 billion in revenue and maintains a $79.8 billion market cap with exactly 147000 employees. After restructuring its volatile US life insurance business (Equitable), AXA's financial narrative in 2026 is entirely focused on profitable commercial Property and Casualty (P&C) lines and employee health benefits. The company is leveraging amounts of AI-driven telematics and localized weather data to reprice risk across its European commercial real estate and logistics portfolios.
The Procter & Gamble Company: Procter & Gamble is functioning as the undisputed sovereign of global consumer staples, extracting wildly compounding cash flows from its entrenched portfolio of daily-use household and personal care brands. Under CEO Jon Moeller, the consumer goods giant generated exactly $84.0 billion in revenue and maintains a $395.0 billion market cap with exactly 107000 employees. The financial narrative in 2026 is entirely defined by extraordinary pricing power discipline; overcoming severe volume declines from years of price increases, P&G extracts lucrative profitability by defending premium positioning for Tide, Gillette, and Pampers against an increasingly aggressive wave of private-label competitors.
Company-Specific SWOT Notes
AXA SA
AXA's presence in 50 countries with balanced revenue across France, Europe, AXA XL, Asia/Africa/EME-LATAM, and other markets provides unmatched resilience.
With a Solvency II ratio of 216% and an all-year P&C combined ratio of 91.
Operating in 50 jurisdictions with diverse regulatory regimes creates operational complexity and compliance risk.
Global health insurance is a high-growth segment driven by aging populations, rising healthcare costs, and expanding middle classes in emerging markets.
Climate change is increasing the frequency and severity of natural catastrophes, challenging historical loss models.
The Procter & Gamble Company
P&G owns trusted brands in categories consumers buy repeatedly, creating resilient demand and pricing power.
Premium brands can lose share if consumers trade down to private label during affordability pressure.
P&G can use innovation, e-commerce execution, and productivity to support premiumization and market share gains.
Retailer brands and digital-native challengers can erode share in categories once assumed to be defensible.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | AXA SA | AXA SA reports the larger revenue base ($110.2B), which serves as a core operational scale signal. |
| Employee Productivity | The Procter & Gamble Company | The Procter & Gamble Company generates higher revenue per employee ($785k / employee vs $750k / employee), signaling greater operational leverage. |
| Valuation Multiple | The Procter & Gamble Company | The Procter & Gamble Company commands a higher valuation multiple (4.7x P/S vs 0.7x P/S), indicating greater investor premium on future growth. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | AXA SA | Founded in 1816 vs 1837. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | AXA SA | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | AXA SA | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | The Procter & Gamble Company | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
AXA SA reports the larger revenue base ($110.2B), which serves as a core operational scale signal.
The Procter & Gamble Company generates higher revenue per employee ($785k / employee vs $750k / employee), signaling greater operational leverage.
The Procter & Gamble Company commands a higher valuation multiple (4.7x P/S vs 0.7x P/S), indicating greater investor premium on future growth.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1816 vs 1837. The earlier pioneer typically commands longer historical institutional legacy.
Who Wins: AXA SA or The Procter & Gamble Company?
Reviewed by Swet Parvadiya, September 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: AXA SA vs The Procter & Gamble Company
Is AXA SA better than The Procter & Gamble Company?
Verdict: Between AXA SA and The Procter & Gamble Company, AXA SA is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, AXA SA comes out ahead in this AXA SA vs The Procter & Gamble Company comparison.
Who earns more — AXA SA or The Procter & Gamble Company?
AXA SA earns more with $110.2B in annual revenue versus The Procter & Gamble Company's $84.0B. AXA SA leads on total revenue based on latest verified figures.
Which company has higher revenue — AXA SA or The Procter & Gamble Company?
AXA SA reported $110.2B, while The Procter & Gamble Company reported $84.0B. The revenue leader is AXA SA based on latest verified figures.
AXA SA revenue vs The Procter & Gamble Company revenue — which is higher?
AXA SA revenue: $110.2B. The Procter & Gamble Company revenue: $84.0B. AXA SA has the larger revenue base of the two companies.
Which company generates more revenue per employee — AXA SA or The Procter & Gamble Company?
The Procter & Gamble Company leads in workforce productivity, generating $785k / employee per employee compared to $750k / employee for AXA SA. AXA SA operates with a team of 147,000 employees while The Procter & Gamble Company employs 107,000.
What are the current strategic priorities for AXA SA vs The Procter & Gamble Company in 2026?
In 2026, AXA SA is prioritizing *Strategic Analysis (September 2026 Update):* As AXA SA navigates the Multiline Insurance & Asset Management market from its headquarters in Paris, France (founded in 1816), a pivotal strategic theme is **Workflow Automation**., while The Procter & Gamble Company is focusing on *Strategic Analysis (September 2026 Update):* As The Procter & Gamble Company navigates the Consumer packaged goods market from its headquarters in Cincinnati, Ohio, United States (founded in 1837), a pivotal strategic theme is **Workflow Automation**.. These strategic vectors determine how each company allocates capital and defends its moat in Multiline Insurance & Asset Management.
How do the valuation multiples of AXA SA and The Procter & Gamble Company compare?
On a price-to-sales basis, AXA SA trades at 0.7x P/S with a market capitalization of $79.8B on $110.2B in revenue, compared to 4.7x P/S for The Procter & Gamble Company with a market capitalization of $395.0B on $84.0B in revenue.
Sources & References
- AXA SA Corporate Website
- AXA SA Annual Report 2025 - Revenue and Financial Data
- axa.com
- axa.com
- www-axa-com.cdn.prismic.io
- SEC EDGAR: The Procter & Gamble Company Annual Filings (10-K, 8-K)
- The Procter & Gamble Company Corporate Website
- The Procter & Gamble Company Annual Report 2025 - Revenue and Financial Data
- sec.gov
- us.pg.com
- pgn2020news.q4web.com
- us.pg.com
Cite This Page
Automatically generated citations for researchers.
CorpDigest. (2026). AXA SA vs The Procter & Gamble Company Comparison. Retrieved , from
CorpDigest. "AXA SA vs The Procter & Gamble Company Comparison." CorpDigest, 2026, . Accessed .
CorpDigest. "AXA SA vs The Procter & Gamble Company Comparison." CorpDigest. 2026. Accessed . .